pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study
Status: COMPLETED
Conditions: Bacterial Infections
Interventions: DRUG: TP-271
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
Status: COMPLETED
Conditions: Stroke|Muscle Spasticity|Motor Neuron Disease
Interventions: BIOLOGICAL: botulinum toxin Type A|BIOLOGICAL: botulinum toxin Type A|DRUG: saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700
Status: COMPLETED
Conditions: Schizophrenia
Interventions: DRUG: Lu AF35700
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer
Status: TERMINATED
Conditions: Prostate Cancer
Interventions: DRUG: 2-deoxyglucose
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104
Status: RECRUITING
Conditions: Paroxysmal Nocturnal Hemoglobinuria
Interventions: DRUG: KP104
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pancreatic Enzyme Suppletion in Pancreatic Cancer
Status: WITHDRAWN
Conditions: Adenocarcinoma of the Pancreas|Normal Pancreatic Exocrine Function
Interventions: OTHER: Timing of start treatment with pancreatic enzymes|OTHER: Timing of start treatment with pancreatic enzymes
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)
Status: NOT_YET_RECRUITING
Conditions: Dermatitis, Atopic|Dermatitis|Eczema|Skin Diseases|Immune System Diseases|Janus Kinase Inhibitors
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B
Status: COMPLETED
Conditions: Hepatitis B
Interventions: BIOLOGICAL: MPL-Adjuvanted recombinant hepatitis B vaccine|BIOLOGICAL: Engerix™-B
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Exhaustive Drainage Versus Fixed-time Drainage for Chronic Subdural Hematoma After One-burr Hole Craniostomy
Status: RECRUITING
Conditions: Hematoma, Subdural, Chronic
Interventions: PROCEDURE: Operation|PROCEDURE: Fixed-time drainage|PROCEDURE: Exhaustive drainage|PROCEDURE: Postoperative computed tomography
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria
Status: COMPLETED
Conditions: Cold Contact Urticaria
Interventions: DRUG: Rupatadine|DRUG: Rupatadine|DRUG: Rupatadine|DRUG: Rupatadine|DRUG: Rupatadine|DRUG: Rupatadine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment
Status: COMPLETED
Conditions: Prostatic Neoplasms|Prostate Neoplasms|Prostate Cancer
Interventions: DRUG: 5-Azacitidine|DRUG: all trans retinoic acid|DRUG: Lupron
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Corneal Epithelial Autograft for LSCD
Status: UNKNOWN
Conditions: Limbal Stem Cell Deficiency
Interventions: PROCEDURE: Corneal epithelial autograft|PROCEDURE: Limbal conjunctival autograft|DEVICE: Femtosecond laser|DEVICE: Diamond knife
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Low Dose Calcium to Prevent Preeclampsia
Status: COMPLETED
Conditions: Pre-Eclampsia|Hypertension, Pregnancy-Induced|Dietary Calcium Deficiency
Interventions: DIETARY_SUPPLEMENT: calcium|BEHAVIORAL: Educational sessions
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: A Study of SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors
Status: RECRUITING
Conditions: Locally Advanced or Metastatic Epithelial Tumor
Interventions: DRUG: SI-B001
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho
Status: COMPLETED
Conditions: Type 2 Diabetes Mellitus (T2D)
Interventions: OTHER: T2D care package|OTHER: Referral to the responsible health facility
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects
Status: COMPLETED
Conditions: Overweight|Obesity
Interventions: DRUG: pramlintide acetate|DRUG: metreleptin|DRUG: placebo-P|DRUG: placebo-M
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes
Status: UNKNOWN
Conditions: Benign Childhood Epilepsy With Centrotemporal Spikes
Interventions: DRUG: conventional antiepileptic drugs|DRUG: oral steroid
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The CARDIO-TTRansform Scintigraphy Sub-study
Status: ACTIVE_NOT_RECRUITING
Conditions: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Interventions: DIAGNOSTIC_TEST: Scintigraphy scan
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D.
Status: COMPLETED
Conditions: Psoriasis Vulgaris
Interventions: DEVICE: Blue light treatment|DRUG: Vitamin D
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Benefits of CTO-PCI in Selected Cases With HFrEF (CTOHFrEF)
Status: COMPLETED
Conditions: Chronic Total Occlusion Vessel
Interventions: PROCEDURE: chronic total coronary occlusion percutaneous intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: The Effects of Two Volitional Interventions to Improve Oral Health Behaviour Among Iranian Adolescents
Status: COMPLETED
Conditions: Oral Health Behavior Change
Interventions: BEHAVIORAL: Implementation intention|BEHAVIORAL: Action planning|BEHAVIORAL: active control group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
Status: COMPLETED
Conditions: Ventricular Ejection Fraction
Interventions: DRUG: Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Tucatinib With Brain and/or Spinal XRT in Patients With HER2+ Metastatic Breast Cancer and LMD
Status: RECRUITING
Conditions: HER2-positive Breast Cancer|LMD
Interventions: DRUG: Tucatinib 150 MG|DRUG: Trastuzumab|DRUG: Capecitabine|RADIATION: Brain & Spinal Radiation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Post Extraction Changes Following Ridge Preservation Using Allogenis Dentin Vs Autogenous Partially Demineralized Dentin
Status: RECRUITING
Conditions: Socket Preservation
Interventions: BIOLOGICAL: Allogeneic Dentin Matrix|BIOLOGICAL: Autogenous Partially Demineralized Dentine Matrix
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults
Status: COMPLETED
Conditions: Prevention of Zika Infection|Zika-Specific Immune Response
Interventions: BIOLOGICAL: VRC-ZKADNA085-00-VP
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Cap-attached Colonoscopy Versus Regular Colonoscopy for Trainees
Status: COMPLETED
Conditions: Colonoscopy|Lower Gastrointestinal Tract
Interventions: DEVICE: Cap-attached Colonoscopy Versus Regular Colonoscopy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
Status: SUSPENDED
Conditions: Prostate Adenocarcinoma|Stage I Prostate Cancer AJCC v8|Stage II Prostate Cancer AJCC v8|Stage IIA Prostate Cancer AJCC v8|Stage IIB Prostate Cancer AJCC v8|Stage IIC Prostate Cancer AJCC v8|Stage III Prostate Cancer AJCC v8|Stage IIIA Prostate Cancer AJCC v8|Stage IIIB Prostate Cancer AJCC v8|Stage IIIC Prostate Cancer AJCC v8
Interventions: DRUG: Aspirin|PROCEDURE: Radical Prostatectomy|BIOLOGICAL: Recombinant Interferon Alfa-2b|DRUG: Rintatolimod
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
Status: COMPLETED
Conditions: Sarcoma, Kaposi|HIV Infections
Interventions: DRUG: Bleomycin sulfate|DRUG: Vincristine sulfate|DRUG: Doxorubicin hydrochloride|DRUG: Zidovudine
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)
Status: COMPLETED
Conditions: Central Centrifugal Cicatricial Alopecia
Interventions: DRUG: Apremilast
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy
Status: NOT_YET_RECRUITING
Conditions: Liver Regeneration|Ursodeoxycholic Acid|Partial Liver Resection
Interventions: DRUG: Ursodeoxycholic acid|OTHER: Standard Medical Treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
Status: ACTIVE_NOT_RECRUITING
Conditions: Multiple Myeloma
Interventions: DRUG: CT-011|BIOLOGICAL: Dendritic Cell Fusion Vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy
Status: NOT_YET_RECRUITING
Conditions: Malignant Neoplasm of Bladder|Muscle Invasive Bladder Carcinoma
Interventions: DRUG: Neoadjuvant Chemotherapy|PROCEDURE: Partial cystectomy with Extended pelvic lymph node dissection|DRUG: Adjuvant systemic therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
Status: UNKNOWN
Conditions: Esophageal Neoplasms
Interventions: DRUG: S1|DRUG: S-1|DRUG: irinotecan
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients
Status: COMPLETED
Conditions: Heart Failures
Interventions: DRUG: Acetazolamide|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Parenting Videos In Primary Care
Status: COMPLETED
Conditions: Discipline Attitudes|Discipline Practices
Interventions: BEHAVIORAL: Discipline Video|BEHAVIORAL: Nutrition Video
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Prevention of Milk-Borne Transmission of HIV-1C in Botswana
Status: COMPLETED
Conditions: HIV Infection|Infant Risk for HIV Infection by MTCT
Interventions: DRUG: Nevirapine|DRUG: No intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works
Status: COMPLETED
Conditions: Diabetes Mellitus, Type 1
Interventions: DRUG: NNC0363-0845|DRUG: Insulin detemir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Assessment of Fractional CO2 Laser in Treatment of Post-surgical Scarring of Cleft Lip
Status: COMPLETED
Conditions: Cleft Lip Post-surgical Scar
Interventions: RADIATION: Fractional CO2 laser
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction
Status: COMPLETED
Conditions: Hypertension With Renal Dysfunction
Interventions: DRUG: LCZ696
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: TRANPAS - TReating Anorexia Nervosa Plus Autism Spectrum
Status: NOT_YET_RECRUITING
Conditions: Anorexia Nervosa|Autism Spectrum Disorder
Interventions: OTHER: Anorexia nervosa plus autism
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma
Status: TERMINATED
Conditions: Pancreas, Adenocarcinoma
Interventions: BIOLOGICAL: Biological/Vaccine: BC-819
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
Status: COMPLETED
Conditions: Bulimia Nervosa|Eating Disorders
Interventions: DRUG: Erythromycin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Improving Optical Diagnosis of Colorectal Polyps Using CADx and BASIC.
Status: COMPLETED
Conditions: Colorectal Cancer|Colorectal Polyp
Interventions: OTHER: Computer-aided diagnosis (CADx)|OTHER: BLI Adenoma Serrated International Classification (BASIC)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
Status: ACTIVE_NOT_RECRUITING
Conditions: Body Mass Index 25 or Greater|BRCA1 Gene Mutation|BRCA2 Gene Mutation|Breast Carcinoma|Cancer Survivor|Chronic Lymphocytic Leukemia|Fatigue|Health Status Unknown|Lynch Syndrome|Ovarian Carcinoma|Overweight
Interventions: DIETARY_SUPPLEMENT: Dietary Intervention|DIETARY_SUPPLEMENT: Dietary Intervention|OTHER: Internet-Based Intervention|OTHER: Internet-Based Intervention|OTHER: Laboratory Biomarker Analysis|OTHER: Questionnaire Administration|BEHAVIORAL: Telephone-Based Intervention|BEHAVIORAL: Telephone-Based Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis
Status: COMPLETED
Conditions: Covid19
Interventions: DRUG: Apixaban 2.5 MG|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)
Status: TERMINATED
Conditions: Alzheimer's Disease
Interventions: DRUG: Tilavonemab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Comparison Between Postoperative Tubular Dressing and a Vacuum Removable Rigid Dressing After Transtibial Amputation
Status: UNKNOWN
Conditions: Amputation Stump|Peripheral Vascular Disease With Complications|Edema Leg|Wound Healing Delayed
Interventions: DEVICE: Vacuum Removable Rigid Dressing (VRRD)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study of Impact of Not Measuring Residual Gastric Volume on Nosocomial Pneumonia Rates
Status: COMPLETED
Conditions: Ventilation-Associated Pneumonia
Interventions: PROCEDURE: monitoring of residual gastric volume|PROCEDURE: not monitoring of residual gastric volume
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study
Status: COMPLETED
Conditions: Bladder Cancer|Radical Cystectomy|Urinary Bladder Neoplasms|Surgery
Interventions: DIETARY_SUPPLEMENT: Boost Plus®|DIETARY_SUPPLEMENT: Impact Advanced Recovery®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Low Level Laser Therapy to Reduce Pain After Breast Augmentation Surgery
Status: COMPLETED
Conditions: Pain
Interventions: DEVICE: Erchonia(R) EML Laser|DEVICE: Placebo Laser
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Biofeedback-based Relaxation Training or Self-alert Training to Alleviate Fatigue in Multiple Sclerosis Patients.
Status: COMPLETED
Conditions: Fatigue|Multiple Sclerosis
Interventions: DEVICE: Biofeedback|BEHAVIORAL: Self-Alert Training|BEHAVIORAL: Relaxation Training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A COmmunity and Tech-Based ApproaCh for Hypertension Self-MANagement
Status: COMPLETED
Conditions: Hypertension|Self-management|Technology|Community-based Participatory Research
Interventions: BEHAVIORAL: Coachman|BEHAVIORAL: Enhanced Usual Care (EUC)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Treatment of Moderate to Severe Lateral Canthal Lines
Status: COMPLETED
Conditions: Lateral Canthal Lines
Interventions: BIOLOGICAL: botulinum toxin|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study of Abemaciclib in Dedifferentiated Liposarcoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Sarcoma|Dedifferentiated Liposarcoma
Interventions: DRUG: Abemaciclib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers
Status: COMPLETED
Conditions: Hepatic Impairment
Interventions: DRUG: Gemigliptin
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides
Status: TERMINATED
Conditions: Mycosis Fungoides|Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Sezary Syndrome
Interventions: PROCEDURE: Extracorporeal Photopheresis|BIOLOGICAL: Mogamulizumab|OTHER: Quality-of-Life Assessment
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Coherence Between Brain Cortical Function and Neurocognitive Performance During Changed Gravity Conditions
Status: COMPLETED
Conditions: Healthy
Interventions: OTHER: Parabolic flight|OTHER: EEG measurement|OTHER: NIRS measurements
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents
Status: TERMINATED
Conditions: Metabolic Syndrome
Interventions: DRUG: Ispaghula husk|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Group Antenatal Care: The Power of Peers for Increasing Skilled Birth Attendance in Achham, Nepal
Status: COMPLETED
Conditions: Prenatal Care
Interventions: OTHER: Group Antenatal Care|OTHER: Individual Antenatal Care
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Preterm Premature Rupture of Membranes (PPROM): Bed Rest Versus Activity Trial
Status: COMPLETED
Conditions: Pregnancy|Pre-term Premature Rupture of Membranes
Interventions: OTHER: Bed Rest|OTHER: Activity
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide
Status: TERMINATED
Conditions: Traumatic Brain Injury
Interventions: DRUG: lacosamide|DRUG: Fosphenytoin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Comparison of Ultrasound Guided Genicular Nerve Blockade Using Current Versus Revised Anatomical Targets
Status: COMPLETED
Conditions: Knee Pain Chronic
Interventions: PROCEDURE: Current Targets
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy
Status: RECRUITING
Conditions: Substance Use Disorders|Opioid Use Disorder, Severe|Opioid Use Disorder, Moderate
Interventions: OTHER: Low Intensity|OTHER: High Intensity
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia
Status: COMPLETED
Conditions: Androgenic Alopecia
Interventions: DIETARY_SUPPLEMENT: 400mg /day during 6 months
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study
Status: COMPLETED
Conditions: Pain
Interventions: DRUG: High dose Remifentanil|DRUG: Naloxone|DRUG: Low dose remifentanil|DRUG: Normal Saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
Status: COMPLETED
Conditions: Anemia, Sickle Cell
Interventions: DRUG: Nitric Oxide|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Microbiota Implementation to Reduce Anastomotic Colorectal Leaks (MIRACLe)
Status: COMPLETED
Conditions: Colorectal Cancer|Surgery|LAP|Anastomotic Leak|Microbial Substitution
Interventions: PROCEDURE: Laparoscopic colorectal resection
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Status: COMPLETED
Conditions: Advanced Adult Hepatocellular Carcinoma
Interventions: DRUG: Dalantercept plus sorafenib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy
Status: COMPLETED
Conditions: Hyperphosphatemia
Interventions: DRUG: Tenapanor|DRUG: Placebo|DRUG: Phosphate Binder Agents
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Pik Lenin High Altitude Research Expedition 2009
Status: COMPLETED
Conditions: Oxidative Stress|Cell-derived Microparticles
Interventions: DIETARY_SUPPLEMENT: antioxidant supplements|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Dose Finding Study of VN-0200
Status: COMPLETED
Conditions: Respiratory Syncytial Virus Infections
Interventions: BIOLOGICAL: VN-0200
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study
Status: ACTIVE_NOT_RECRUITING
Conditions: Vulvar Intraepithelial Neoplasia|Condylomata Acuminata
Interventions: DEVICE: CUSA (Cavitronic Ultrasonic Surgical Aspirator)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Breathing Control Exercises in Patients With Chronic Obstructive Pulmonary Disease.
Status: COMPLETED
Conditions: Severe Chronic Obstructive Pulmonary Disease
Interventions: BEHAVIORAL: Standard Occupational Therapy|BEHAVIORAL: Occupational Therapy with Breathing Control Exercises
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Art as Healing: A Community-informed Art-based Programme (CiAbP) for Reintegrating Ex-offenders Into Society in Nigeria
Status: NOT_YET_RECRUITING
Conditions: Trauma|Depression|Anxiety and Fear
Interventions: BEHAVIORAL: Community-informed art-based programme|OTHER: Government Media Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Preoperative Cognitive Training for Postoperative Cognitive Dysfunction
Status: TERMINATED
Conditions: Cognitive Decline|Cognitive Impairment|Cognitive Deterioration
Interventions: BEHAVIORAL: Cognitive training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Palbociclib After CDK and Endocrine Therapy (PACE)
Status: ACTIVE_NOT_RECRUITING
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Palbociclib|DRUG: Fulvestrant|DRUG: Avelumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis
Status: COMPLETED
Conditions: Pouchitis
Interventions: DRUG: AMT-101 (oral)-Dose A|DRUG: AMT-101 (oral)-Dose B
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
Status: COMPLETED
Conditions: Hepatic Impairment
Interventions: DRUG: tasimelteon
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: A Comparison of McGrath MAC Videolaryngoscopy and Macintosh Laryngoscopy for Orotracheal Intubation in Children With Torticollis
Status: COMPLETED
Conditions: Anesthesia, Endotracheal
Interventions: DEVICE: McGrath MAC videolaryngoscopy|DEVICE: Macintosh Laryngoscopy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Time and Nutrient-Dependent Effects of Aerobic Exercise on Metabolism in Adults (TANDEM Study)
Status: RECRUITING
Conditions: Overweight and Obesity|Healthy
Interventions: BEHAVIORAL: Fasted-AM|BEHAVIORAL: Fed-AM|BEHAVIORAL: Fasted-PM|BEHAVIORAL: Fed-PM
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department
Status: UNKNOWN
Conditions: Pain
Interventions: DRUG: Buprenorphine|DRUG: Morphine Sulfate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)
Status: COMPLETED
Conditions: Lymphoma
Interventions: DRUG: BI 2536
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery
Status: COMPLETED
Conditions: Ischemic Stroke
Interventions: DRUG: Extended-Release Niacin|DRUG: Extended-Release Niacin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Telehealth-Education-Based Program for Military Caregivers of Injured Service Members With Head Injuries
Status: COMPLETED
Conditions: Traumatic Brain Injuries
Interventions: BEHAVIORAL: Problem-Solving Training (PST)|BEHAVIORAL: Attention Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy
Status: COMPLETED
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: PROCEDURE: Quality-of-Life Assessment|OTHER: Questionnaire Administration|OTHER: Placebo|PROCEDURE: Fatigue Assessment and Management|PROCEDURE: Sleep Disorder Therapy|DRUG: Armodafinil|PROCEDURE: Quality-of-life assessment|OTHER: Questionnaire Administration|PROCEDURE: Fatigue Assessment and Management|PROCEDURE: Management of Therapy|PROCEDURE: Sleep disorder therapy|PROCEDURE: cognitive assessment|PROCEDURE: Quality of Life assessment|OTHER: Questionnaire Administration|OTHER: Placebo|PROCEDURE: Fatigue assessment and management|PROCEDURE: Management of therapy and complications|PROCEDURE: Sleep disorder therapy|DRUG: Armodafinil|PROCEDURE: Cognitive Assessment|PROCEDURE: Quality of Life Assessment|OTHER: Questionnaire Administration|PROCEDURE: Fatifue assessment and management
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Investigation of the Role of Hemodynamics in Re-stenosis of CABG Patients
Status: COMPLETED
Conditions: Coronary Artery Disease|Stable Angina|Unstable Angina
Interventions: OTHER: Computed Tomography Angiography|OTHER: Intra-operative graft flow rate measurement
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
Status: UNKNOWN
Conditions: Endometrial Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Undifferentiated Carcinoma|Recurrent Uterine Corpus Carcinoma|Stage III Uterine Corpus Cancer AJCC v7|Stage IIIA Uterine Corpus Cancer AJCC v7|Stage IIIB Uterine Corpus Cancer AJCC v7|Stage IIIC Uterine Corpus Cancer AJCC v7|Stage IV Uterine Corpus Cancer AJCC v7|Stage IVA Uterine Corpus Cancer AJCC v7|Stage IVB Uterine Corpus Cancer AJCC v7
Interventions: DRUG: Carboplatin|OTHER: Laboratory Biomarker Analysis|DRUG: Metformin Hydrochloride|DRUG: Paclitaxel|OTHER: Placebo Administration|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy
Status: RECRUITING
Conditions: Radial Artery Occlusion
Interventions: DRUG: Subcutaneous enoxaparin sodium|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: The Effects of a Water Based Exercise Programme and a Land Based Exercise Programme on Women Experiencing Pregnancy Related Pelvic Girdle Pain
Status: COMPLETED
Conditions: Pregnancy Related|Pelvic Girdle Pain
Interventions: OTHER: water based exercise|OTHER: land based exercise|BEHAVIORAL: advice
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin
Status: UNKNOWN
Conditions: Helicobacter Pylori Infection
Interventions: DRUG: Levofloxacin|DRUG: tinidazole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers
Status: COMPLETED
Conditions: Glomerular Filtration Rate|Acute Kidney Injury
Interventions: DRUG: Below target dose MP-3180|DRUG: At target dose MP-3180|DRUG: 2 times above target dose MP-3180|DRUG: 4 times above target dose MP-3180|DEVICE: ORFM prototype|OTHER: Iohexol comparator
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation
Status: UNKNOWN
Conditions: Liver Transplantation|Blood Loss
Interventions: DRUG: Iron Carboxymaltose|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT